(Q40516350)

21 September 2017

title

Effect of fenofibrate on serum inflammatory markers in patients with high triglyceride values (English)

1 reference

21 September 2017

1 reference

Dimitri P Mikhailidis

6

object named as

Dimitri P Mikhailidis

1 reference

21 September 2017

Vasilis Tsimihodimos

1

1 reference

21 September 2017

Angeliki Kostoula

2

1 reference

21 September 2017

Anna Kakafika

3

1 reference

21 September 2017

Eleni Bairaktari

4

1 reference

21 September 2017

Alexandros D Tselepis

5

1 reference

21 September 2017

Moses Elisaf

7

1 reference

21 September 2017

publication date

1 March 2004

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

21 September 2017

published in

1 reference

21 September 2017

volume

9

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

27-33

1 reference

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Interleukin-6 and the acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Lipoprotein (a) and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Platelet-activating factor acetylhydrolases in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

RU486 antagonizes the inhibitory effect of peroxisome proliferator-activated receptor alpha on interleukin-6 production in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

Distributions of C-reactive Protein Measured by High-Sensitivity Assays in Apparently Healthy Men and Women from Different Populations in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I105

10.1177/107424840400900I105

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference